GANGLIONEUROMA
Clinical trials for GANGLIONEUROMA explained in plain language.
Never miss a new study
Get alerted when new GANGLIONEUROMA trials appear
Sign up with your email to follow new studies for GANGLIONEUROMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New scan could spot rare tumors earlier and more safely
Diagnosis OngoingThis study is testing a new type of PET/CT scan that uses a special tracer (68Ga-DOTATOC) to find neuroendocrine tumors and other related cancers. The goal is to see if this scan is safer and more sensitive than current imaging methods. About 800 people with known or suspected tu…
Matched conditions: GANGLIONEUROMA
Sponsor: British Columbia Cancer Agency • Aim: Diagnosis
Last updated May 26, 2026 08:33 UTC
-
New scan may outshine standard test for Kids' rare tumors
Diagnosis OngoingThis study tests whether a special PET/CT scan using a radioactive tracer called 68Ga-DOTATATE can better detect neuroendocrine tumors (like neuroblastoma) in children and young adults up to age 30. The scan is compared to the standard MIBG scan to see which one more clearly show…
Matched conditions: GANGLIONEUROMA
Phase: EARLY_PHASE1 • Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated May 12, 2026 13:40 UTC